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Background: While overactive bladder is often managed in the primary care setting, a number of barriers including
embarrassment, poor communication, and low patient adherence contribute to the under-treatment of patients
with burdensome urinary symptoms. In order to address these challenges, it is crucial to have a fundamental
understanding of patient perspectives toward OAB and urinary symptoms. To meet this aim, researchers designed
and conducted a study to identify patients’ knowledge, experiences and attitudes, barriers to treatment adherence,
and desires and tendencies regarding patient/clinician communications.
Methods: A mixed-methods qualitative/quantitative needs assessment of patients with overactive bladder and/or
urinary symptoms. Researchers conducted in-depth qualitative interviews via telephone with 40 patients. Interview
results informed the design and dissemination of a quantitative survey, which was completed by 200 self-selected
respondents who had previously identified themselves as having overactive bladder or bladder problems. Statistical
and qualitative analysis of results were conducted.
Results: Among survey respondents, an average of 3.5 years elapsed between symptom onset and seeking
diagnosis by a physician. In the long term most patients do not experience improvement in symptoms. Medication
non-adherence is common and is related to therapy effectiveness and adverse effects. Patients clearly indicate that
communication and patient/physician relationships are important to them and they would prefer the clinician
initiate the conversation on overactive bladder. Patient experiences, perspectives, and attitudes toward their bladder
symptoms differ in many ways from clinicians’ assumptions.
Conclusions: The significant time gap between symptom onset and diagnosis indicates ongoing need for screening
and diagnosis of overactive bladder. Contrary to guideline recommendations, urinalysis and physical examination are
not widely used in clinical practice. Many patients experience no improvement in symptoms over time. Patients
indicate that clinician/patient relationships and communication regarding their condition are important.
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Overactive bladder (OAB) is a clinical symptom complex
that affects a significant number of primary care patients
in the United States. It is defined by the International
Continence Society (ICS) as the presence of urinary ur-
gency, usually accompanied by frequency and nocturia,
with or without urgency urinary incontinence, in the ab-
sence of urinary tract infection or other obvious path-
ology [1]. The estimated worldwide prevalence of OAB
is anticipated to increase from 10.7% in 2008 to 10.9%* Correspondence: aholthusen@ipmameded.org
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reproduction in any medium, provided the orby 2018, affecting 546 million individuals [2]. A recent
study suggests that only 45.7% of patients with probable
OAB discussed the symptoms with a health care pro-
vider and only 8.1% were receiving treatment [3]. While
usually not life threatening, symptoms of OAB signifi-
cantly lower quality of life by adversely affecting self-
esteem, family relations, sexual satisfaction, professional
and social life, and overall perception of health [4-7]. In
addition, the direct financial costs related to diagnosis,
treatment, and consequences of the disease were esti-
mated at $12.6 billion during 2000 [8].
While OAB can often be diagnosed and managed suc-
cessfully in the primary care setting, several barriersl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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burdensome symptoms. Primary care providers may lack
training in this area or lack clinical awareness of ef-
fective evaluation and management strategies. One sur-
vey of general practitioners found the need for increased
awareness among clinicians and the general population.
Inadequate communication between patients and pro-
viders has limited successful diagnosis, treatment, and
management of OAB [9,10]. Many patients are embar-
rassed or reluctant to mention urinary symptoms during
office visits. Patients may feel their symptoms are not
severe enough to warrant consulting a clinician, do not
represent a valid medical condition, or perceive their
symptoms to be unavoidable outcomes of aging or comor-
bidities [9]. For example, a recent survey found that more
than half of women who discussed OAB with a provider
had waited more than a year to seek treatment for their
symptoms [9] and only 44% of men with symptoms of
urinary incontinence had consulted a physician [11].
Another barrier to effective management of OAB is
poor patient adherence or persistence to treatment [12].
The causes of non-adherence are multifactorial and may
include unclear or unrealistic treatment goals, side effects
or inconvenience of therapy, cost, or simply forgetting to
follow a treatment regimen.
The clinical needs in the diagnosis, management, and
treatment of OAB are well established. Current evidence-
based medical literature documents the scope of the
problem, its effect on patient health and quality of life,
and guidelines for effective diagnosis and management.
Successful clinical outcomes and patient satisfaction are
dependent upon timely identification of symptoms, appro-
priate evaluation, effective communication and patient
education, and realistic treatment plans and goals. To
improve clinical outcomes and patient satisfaction, it is es-
sential that health care providers have a fundamental un-
derstanding of patient perspectives toward OAB and
incontinence. Prior studies reflecting patient perspectives
have identified the negative effects of OAB on health-
related quality of life [13] as well as dissatisfaction with
OAB care and miscommunication [14]. With the goal of
improving the quality of care for patients with OAB, the
intent of this study was to contribute additional patient
perspective related to knowledge and attitudes, symptoms
and history, screening, testing and diagnosis, manage-
ment, satisfaction of treatment, adherence to treatment,
and provider/patient communication. Results will provide
needed complementary patient perspective to existing
data on clinician practice gaps regarding treatment and
management of OAB and incontinence.
Methods
This IRB-approved study consisted of qualitative in-
depth patient interviews and quantitative online patientsurveys. Survey respondents consisted of individuals in the
ResearchNow database that had previously self-identified
as having symptoms of OAB or bladder dysfunction.
ResearchNow is a company that provides researchers
access to panels of individuals related to various topics.
ResearchNow recruited participants for the interviews and
survey based on eligibility criteria. Researchers employed
a double opt-in process in which participants who opted
in after receiving a personalized e-mail invitation were
sent a follow up e-mail confirmation validating their par-
ticipation a second time. The protocol was approved by
the University of North Texas Health Science Center
Institutional Review Board.
Qualitative interviews
Forty in-depth qualitative interviews were conducted
with patients who were pre-screened for a history of
OAB and/or urinary incontinence. Interviews lasted 30–
60 minutes and were conducted by study-specific trained
telephone interviewers. The purpose of the interviews
was to identify issues and influences on clinical behavior
from a patient perspective. These interviews also helped
to identify key areas where further clinician/patient educa-
tional interventions may be needed and provided the basis
for development of the patient survey. Questions pertain-
ing to the type of treatment and adherence to treatment
for OAB were open ended in the qualitative interviews.
Verbal consent was obtained from participants via tele-
phone before the interviews were conducted.
Survey
A quantitative patient survey and assessment tool
(Additional file 1) was developed based on responses
from the qualitative interviews and distributed via e-mail
to individuals who self-identified as experiencing OAB
and/or urinary incontinence. Participants were eligible if
they had experienced symptoms of urgency, frequency,
leakage, and/or urinary incontinence. A total of 200
surveys were completed. The survey took fewer than
15 minutes to complete on average and consisted of
two components focusing on patient experience and
knowledge/attitudes. The experience portion of the
assessment gathered information about actual patient
and clinician behaviors pertaining to the assessment,
diagnosis, and management of OAB, including patient
perceptions about how OAB had been managed by their
personal healthcare provider. The patient knowledge and
attitude portion of the assessment quantified patients’
basic knowledge of the epidemiology, pathophysiology,
diagnosis, and treatment of OAB. This tool also assessed
attitudes about OAB, its treatments, and providers who
manage this condition. The following treatments for
OAB were assessed in the survey: medication, pelvic
floor muscle exercises, reducing liquids, reducing caffeine,
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the bladder. Subjects were also given an “other” option to
discuss any treatments not covered in the list. A cover let-
ter that explained confidentiality issues and other consent
elements was included with each survey.
Data analysis
Data analyses for survey responses were conducted using
SPSS. Descriptive statistics such as means and frequencies
are provided. Differences in knowledge scores for re-
spondent gender, respondent age (41–60 and ≥ 61 years),
physician gender, and physician specialty were determined
using analysis of covariance (ANCOVA) to control for the
lag time between when the respondent first noticed symp-
toms and when he/she talked with a doctor about their
symptoms. Analysis of variance (ANOVA) was used to de-
termine the difference in knowledge score with frequency
of communication between the patient and physician and
type of educational material utilized. Participants were
asked if they agree or disagree with the statement “OAB is
just a part of aging, I just have to live with it”. Responses
were scored on a Likert scale, and the mean score was
compared between age group and gender using an inde-
pendent sample t test. All included surveys had complete
data.
Results
Interviewees included 31 females and 9 males ranging
from 40 to 80 years of age, with an average age of 63.
They had a 3–15-year history of bladder and/or urinary
symptoms. Most of the interviewees had a primary care
provider to manage their symptoms. Several men were
treated by urologists, and two women were cared for by
urogynecologists. Two hundred U.S. participants from
37 states completed the quantitative survey assessment.
Responses from six participants were found to be in-
complete and were excluded from analysis, resulting in a
sample size of 194. Ninety-eight (51%) were men and 96
(49%) were women. Sixty-four (33%) participants were
41–60 years of age, and 130 (67%) of participants were
61 years of age or older.
Patient knowledge and attitudes
Interviewees demonstrated a good understanding of their
own condition and treatments. There was mixed under-
standing of treatment methods and goals of therapy in
general. Patient knowledge and attitudes were assessed via
survey based on correct responses to 6 questions. Partici-
pants overall demonstrated a fairly high level of know-
ledge about OAB, with a 65% correct response rate on
average. Both female respondents (p < 0.001) and re-
spondents who saw a female physician (p < 0.001) scored
higher, on average, on the knowledge scale as compared
to male respondents and respondents who saw a malephysician. Additionally, respondents who saw urogynecol-
ogists or obstetrician/gynecologists had higher average
scores as compared those who saw a primary care phys-
ician, urologist, or other physician (p = 0.004). Patient age,
frequency of communication, or type of educational ma-
terial provided had no statistical association with overall
patient knowledge of OAB. Regarding attitudes about
OAB, the majority of respondents (65.5%) disagreed with
the statement ‘OAB is just part of aging; I just have to live
with it’. Further analysis reveals that while there was no
difference in response to this question according to age
group, men were statistically more likely to agree with the
statement (p < 0.033).
Symptoms and history
Interviewees reported having experienced common
symptoms of OAB such as urgency, frequency, nocturia,
and leakage. Many had little to no urinary incontinence
beyond minor leakage, yet they reported that symptoms
were troublesome and that the effect on daily life was
significant. Participants reported taking a number of de-
liberate steps to self-manage their symptoms such as
using pads and restricting fluids. Several reported bath-
room mapping and restricting their travel to short trips.
Quantitative survey results confirmed these findings
with 76% of respondents reporting that they ‘try to learn
where bathrooms are located so [they] can get to them
quickly if needed’. Responses also showed that participants
often suffered for long periods of time before consulting
a clinician. On average, respondents had experienced
urinary and bladder symptoms for 9 years (sd = 9.3) while
only being under a physician’s care for these symptoms for
5.8 (sd = 6.0) years, resulting in an average time gap of
3.5 years between symptom onset and treatment initiation.
Disease screening
Interviews suggested that physicians seldom initiate
communication about urinary or bladder issues. Partici-
pants reported that physicians had engaged patients re-
garding symptoms after the participants themselves had
mentioned them. Patients, however, prefer that their pro-
vider initiate discussion about urinary symptoms because
they find it embarrassing to bring the topic up themselves.
Survey results show similar findings in which 42% of re-
spondents raised the issue of urinary or bladder symptoms
themselves while seeing their health care provider for an
unrelated concern. Only 14% of survey participants re-
ported that ‘my doctor asked me about urinary or bladder
symptoms’.
Testing and diagnosis
Qualitative interviews assessing testing and diagnosis of
OAB showed that many interviewees had a urinalysis
performed during their assessment. Some reported having
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stress testing performed. Other patients had undergone
no specific testing, including physical examination and
urinalysis, despite current guidelines from the American
Urological Association recommending that these be per-
formed on all patients with signs and symptoms of OAB
[15]. Survey results confirm that urinalysis was the most
commonly performed test, though only 56% of respon-
dents reported its use during their evaluation. Only 44%
reported having had a physical examination (vagina or
prostate), while 40% reported a bladder-emptying test.
Management
Interviewees reported that they felt physicians were
quick to prescribe medication even when the patients
did not necessarily think it was needed. Sixty-two per-
cent of survey respondents indicated that medications
had been recommended or prescribed by their doctor.
Specific pharmacologic treatments mentioned included
anti-muscarinic agents, α–blockers, and vaginal estrogen
cream. Few patients reported that their physician offered
non-pharmacologic or behavioral management of their
symptoms. Only 29% and 31% of surveyed participants
reported being provided bladder training and pelvic floor
exercises, respectively. Some patients indicated that they
were on no treatment by their own choice, either having
never started or having discontinued their medications
due to side effects and/or lack of efficacy. Side effects re-
ported as a cause of medication cessation included the
common anticholinergic effects of dry mouth, constipa-
tion, and blurred vision.
When questioned about the importance of managing
OAB as compared to other medical conditions, inter-
viewees indicated that OAB symptoms bother them
enough that they want to have it addressed by their
physician. Similarly, survey results showed that 31% of
respondents believe it is ‘very important’ that their OAB
or urinary problems be treated. Only 1% indicated that it
was ‘not at all important’.
Satisfaction & effectiveness of treatment
Regarding satisfaction with current treatment regimens,
most responses indicated moderate satisfaction with only
9% of survey respondents being ‘very satisfied’ with their
current treatment. In order to assess the effectiveness of
therapy, survey participants were asked to rate both their
initial and current symptoms on a Likert scale from 1
(not bothered) to 5 (very bothered). Responses showed
virtually no change in symptom severity between the
time of symptom onset and present day.
Treatment adherence
Adherence to treatment as reported by interviewees was
low overall, initially starting high but ultimately fallingover time. Adherence decreased as patients perceived
treatments becoming less effective. Often titration to
higher doses of medications occurred, sometimes result-
ing in increased side effects and eventual dosage reduc-
tion or discontinuation. Medication non-adherence was
mostly a result of side effects, though ineffectiveness and
cost were cited as other reasons. Adherence to treatment
with medication was higher than adherence to lifestyle
changes and pelvic floor exercises. Ineffectiveness and
not remembering were the key reasons that patients
failed to continue with less invasive treatments such as
pelvic floor exercises. Respondents who reported more
frequent communication with their provider about OAB
had higher levels of adherence than those with less fre-
quent communication (p = 0.018).
Provider/patient communication
Interviewees reported overall dissatisfaction with clini-
cians’ frequency and quality of communication regarding
OAB. While most felt their physicians have an under-
standing and appreciation of their condition, some re-
ported that their provider ‘doesn’t get it at all’. Physician
understanding was equated with being a ‘good listener’.
Communication between female patients and male physi-
cians seemed the most problematic with women report-
ing such impressions as ‘he doesn’t understand’, ‘is not
concerned’, or ‘this is not important to him’.
Survey respondents reported the frequency of OAB
discussions with their physicians. Forty-one percent said
that they discussed urinary or bladder symptoms ‘occa-
sionally’, while 32% reported discussions ‘on nearly every
visit’. These findings were similar to interview responses
where follow-up conversations initiated by either patient
or physician after initial diagnosis and treatment rarely
occurred. It is evident that patients prefer regular discus-
sion of OAB with their physician, with 75% of those sur-
veyed rating this issue as ‘very important’.
Patient education
Interview responses to questions about patient education
were variable. Patients reported receiving mixed expla-
nations with varied terminology from clinicians. Some
patients utilized the terminology ‘overactive bladder’ or
‘OAB’. Others mentioned ‘incontinence’ or ‘urge incon-
tinence’, but when questioned further, described the
symptoms of OAB. The amount of detailed informa-
tion that was provided to patients was mixed; some pa-
tients received little to no information about OAB while
others received educational materials in the form of
printed brochures. Many patients had conducted their
own research regarding OAB via the internet. Survey
results were similar; 57% of respondents reported receiv-
ing no educational materials and 37% reported receiving
printed information.
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This study provides clinicians a much-needed patient
perspective regarding the diagnosis, treatment, and man-
agement of OAB that can be utilized to improve patient-
centered outcomes. It is evident that there exists a
need for improved screening and diagnosis of OAB. This
study identified a significant time period (3.5 years)
between onset of symptoms and eventual diagnosis by
a clinician. In addition, only a small minority of clinicians
questioned patients about urinary symptoms. Though it
was more common for patients to initiate the discussion
about bladder issues, the embarrassment and reluctance
to discuss the topic presents a major barrier for patients,
ultimately resulting in unidentified and untreated symp-
toms. Proactive screening and communication on the part
of the clinician via simple office strategies may make a sig-
nificant difference in ensuring timely diagnosis.
Despite available published guidelines for the diagnosis
and evaluation of patients with symptoms of OAB [15],
results revealed that appropriate diagnostic and assess-
ment tools were not widely used in clinical practice.
Though urinalysis and physical examination should be
performed on all patients with symptoms of overactive
bladder, a very large percentage of the study population
did not have them performed. This represents a signifi-
cant practice gap for health care providers and its cause
merits further investigation.
With regard to outcomes of treatment for OAB, it was
clear that in this study patients’ long-term therapy needs
were not being met. Patients reported virtually no change
in the severity of symptoms from onset to present day,
despite an average time gap of almost 9 years. This may
be the result of several barriers that include unrealistic ex-
pectations, lack of provider follow-up and communica-
tion, providers not following treatment guidelines, and
non-adherence to treatment due to side effects and/or
cost. Despite being effective, non-invasive, and having vir-
tually no adverse effects, behavioral therapies such as
bladder training and pelvic exercises were associated with
the lowest adherence rates in this study. Similarly, low ad-
herence rates to behavioral interventions such as pelvic-
floor muscle exercises and delayed voiding are low among
women with urge incontinence when prescribed in ad-
junct to drug therapy [16]. Providers will need to identify
and implement proven strategies to assess and encourage
adherence by defining clear treatment goals, creating a
treatment plan utilizing educational and instructional ma-
terials, and frequently communicating with patients to
identify potential barriers to adherence.
Patients indicated that communication and patient/
physician relationships are important. They prefer that
the provider initiate conversations about bladder issues
and value ongoing communication and follow up after
diagnosis. In addition, patients who communicated morefrequently with their providers had higher adherence to
treatment. This is not surprising since physician/patient
communication is associated with treatment adher-
ence [17]. Communication should clearly define treatment
goals and strategies prior to initiating drug therapy. Many
patients felt providers were too quick in prescribing medi-
cations. Patients seek knowledge about their condition
and often have to obtain this information from the inter-
net, since the majority of patients in this study were not
provided with any educational materials about their condi-
tion. Providers need to make an effort to identify and
provide educational and training resources to patients
with OAB.
Current health care models emphasize communica-
tion, clinical outcomes, and patient satisfaction. This
study has helped identify patients’ experiences and per-
spectives related to the overall diagnosis and manage-
ment of OAB. In doing so, it has identified practice gaps
related to communication, timely diagnosis, evaluation,
treatment, long-term follow-up, adherence to therapy,
and education. Improving performance in each of these
areas would serve to improve the quality of life of those
patients suffering from the symptoms of OAB.
Several limitations to this study should be noted. First,
the survey was developed using responses from the
qualitative interviews. The survey was not pilot tested
and was not validated. Therefore, the results should be
interpreted with caution. Additionally, participants were
recruited using a company that compiles panels of par-
ticipants. This introduces a selection bias that may or
may not affect the overall outcomes. The results may
not represent the view of all patients with OAB. Finally,
the International Continence Society’s definition of OAB
was not used. The current research provides pilot data
to develop a larger study to examine the patient’s per-
spective of OAB and their quality of life.
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